L-Arginine and Sickle Cell Disease

Last updated: June 10, 2010
Sponsor: Hospital de Clinicas de Porto Alegre
Overall Status: Completed

Phase

3

Condition

Sickle Cell Disease

Red Blood Cell Disorders

Treatment

N/A

Clinical Study ID

NCT01142219
04-487 cep@hcpa.ufrgs.br
  • Ages > 1
  • All Genders

Study Summary

One of the main problems in sickle cell disease is the decreased bioavailability of nitric oxide and arginine. This study was designed to assess if treating sickle cell disease patients with L-arginine would improve pulmonary arterial pressure and other aspects.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of sickle cell disease confirmed through hemoglobin electrophoresis

  • Genotypes SS, SC and Sβ thalassemia

  • Age > 1 year

Exclusion

Exclusion Criteria:

  • Liver dysfunction (alanine aminotransferase ALT > 3 times the normal levels

  • Renal dysfunction (creatinine > twice the normal levels)

  • Increase in methemoglobin levels (> 5 times the normal levels)

  • History of recent stroke (< 1 month) and priapism

  • Pregnancy

  • Allergy to L-arginine

  • Use of sildenafil, calcium channel blockers, nitroglycerin or other nitrates

Study Design

Total Participants: 40
Study Start date:
September 01, 2006
Estimated Completion Date:
October 31, 2009

Study Description

This is a phase III, randomized, double-blind, placebo-controlled clinical trial with sickle cell disease patients older than 1 year of age. The patients were randomly assigned to take 0.1 g/kg/day of either L-arginine or placebo orally. Adverse events were monitored by a safety committee. The variables were assessed while patients were in remission, as part of their routine care: weight, blood pressure, full blood cell count, creatinine and dosage of methemoglobin at baseline and at each follow-up visit. Peripheral oxygen saturation (SpO2), fetal hemoglobin, lactate dehydrogenase and tricuspid regurgitant jet velocity were measured through transthoracic Doppler echocardiogram before and after treatment.

Connect with a study center

  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, RS 90035-001
    Brazil

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.